Retrospective Study to Evaluate the Feasibility of Ovarian Preservation in Patients With Endometrial Carcinoma
ECWOP
Study for Elevate the Feasibility of Ovarian Preservation With Endometrial Carcinoma
1 other identifier
observational
300
1 country
1
Brief Summary
Endometrial cancer is one of the most common female malignancies in the United States, and has increased in incidence in Taiwan in recent decades.A recent population-based analysis noted that 4% of endometrial cancers occurred in women aged 40 years or younger, furthermore it is up to 15% in Taiwan according to the data of cancer registry. The standard treatment of endometrial cancer results in surgical menopause and places patients at risk for the long-term sequelae of estrogen deprivation. The goal of this study was to determine the frequency of a coexisting ovarian malignancy and to evaluate the outcome of ovarian preservation in women with treatment for endometrial cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2000
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2000
CompletedFirst Submitted
Initial submission to the registry
June 14, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2011
CompletedFirst Posted
Study publicly available on registry
March 21, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedMarch 27, 2012
March 1, 2012
11.3 years
June 14, 2011
March 24, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
from the time of diagnosis to the time of disease recurrence or last follow time
the time of diagnosis to the time of disease recurrence or last follow time
disease recurrence or last follow time, up to one year
Study Arms (2)
ovarian preservation
endometrial cancer with ovarian preservation
oophorectomy
endometrial cancer without ovarian preservation
Interventions
endometrial cancer with or without oophorectomy
Eligibility Criteria
The investigators retrospectively reviewed the cases of 150 patients who had primary surgery with early stage endometrial cancer between January 1989 and December 2009
You may not qualify if:
- MMMT, type 2 endometrial cancer
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Taipei Veterans General Hospital
Taipei, ROC, 11217, Taiwan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Yi-Jen Chen
Department of Obstetric and Gynecology, Taipei Veterans General Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
June 14, 2011
First Posted
March 21, 2012
Study Start
August 1, 2000
Primary Completion
December 1, 2011
Study Completion
December 1, 2012
Last Updated
March 27, 2012
Record last verified: 2012-03